Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
St. Jude Medical Center
mi
from
Fullerton, CA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
St. Jude Medical Center
mi
from
Fullerton, CA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Moores UCSD Cancer Center
mi
from
La Jolla, CA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Moores UCSD Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Stanford Cancer Institute
mi
from
Palo Alto, CA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Stanford Cancer Institute
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Innovative Clinical Research Institute, LLC
mi
from
Whittier, CA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Innovative Clinical Research Institute, LLC
mi
from
Whittier, CA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Advanced Medical Specialists
mi
from
Miami, FL
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Advanced Medical Specialists
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Lewis Hall Singletary Oncology Center
mi
from
Thomasville, GA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Lewis Hall Singletary Oncology Center
mi
from
Thomasville, GA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Karmanos Cancer Institute
mi
from
Detroit, MI
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
New Mexico Cancer Care Alliance
mi
from
Albuquerque, NM
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
New Mexico Cancer Care Alliance
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Weill-Cornell Medical College
mi
from
New York, NY
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Oncology Hematology Care
mi
from
Cincinnati, OH
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Oncology Hematology Care
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Northwest Cancer Specialist, P.C
mi
from
Portland and Yualatin, OR
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Northwest Cancer Specialist, P.C
mi
from
Portland and Yualatin, OR
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Albert Einstein Cancer Center
mi
from
Philadelphia, PA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Albert Einstein Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Tennessee Oncology-Chattanooga
mi
from
Chattanooga, TN
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Tennessee Oncology-Chattanooga
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Tennessee Oncology PPLC SCRI
mi
from
Nashville, TN
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Tennessee Oncology PPLC SCRI
mi
from
Nashville, TN
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Texas Oncology
mi
from
Bedford and Grapevine, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Texas Oncology
mi
from
Bedford and Grapevine, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Texas Oncology - Dallas
mi
from
Dallas, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Texas Oncology - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Texas Oncology - Longview and Tyler
mi
from
Longview and Tyler, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Texas Oncology - Longview and Tyler
mi
from
Longview and Tyler, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Cancer Care Center of South Texas-HOAST
mi
from
New Braunfels and San Antonio, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Cancer Care Center of South Texas-HOAST
mi
from
New Braunfels and San Antonio, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Brooke Army Medical Center
mi
from
San Antonio, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Brooke Army Medical Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Scott and White Healthcare
mi
from
Temple, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Scott and White Healthcare
mi
from
Temple, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
University of TX Health Science Center at Tyler
mi
from
Tyler, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
University of TX Health Science Center at Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Northwest Cancer Specialist
mi
from
Vancouver, WA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Northwest Cancer Specialist
mi
from
Vancouver, WA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
USC/Norris Comprehensive Cancer Center and LAC/USC Medical Center
mi
from
Los Angeles, CA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
USC/Norris Comprehensive Cancer Center and LAC/USC Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Rocky Mountain Cancer Centers
mi
from
Multiple Locations, CO
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Rocky Mountain Cancer Centers
mi
from
Multiple Locations, CO
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Montefiore Medical Center
mi
from
The Bronx, NY
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Montefiore Medical Center
mi
from
The Bronx, NY
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Oncology Hematology Consultants PA
mi
from
Fort Worth, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Oncology Hematology Consultants PA
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Texas Oncology - Forth Worth
mi
from
Fort Worth, TX
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Texas Oncology - Forth Worth
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Virginia Oncology Associates
mi
from
Multiple Locations, VA
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Virginia Oncology Associates
mi
from
Multiple Locations, VA
Click here to add this to my saved trials
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated:  8/23/2017
Royal North Shore Hospital
mi
from
St Leonards,
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase III Double-blinded, Placebo Controlled Study of Xilonix™ for Improving Survival in Metastatic Colorectal Cancer
Status: Enrolling
Updated: 8/23/2017
Royal North Shore Hospital
mi
from
St Leonards,
Click here to add this to my saved trials
Polymem vs. Bacitracin/Xeroform in Treating Burn Wounds
Prospective Randomized Trial of Polymem vs. Bacitracin/Xeroform for Superficial Second Degree Burns
Status: Enrolling
Updated:  8/28/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Polymem vs. Bacitracin/Xeroform in Treating Burn Wounds
Prospective Randomized Trial of Polymem vs. Bacitracin/Xeroform for Superficial Second Degree Burns
Status: Enrolling
Updated: 8/28/2017
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Osteopathic Otitis Media Research Study
Effect of Osteopathic Manipulative Medicine (OMM) on the Duration of Middle Ear Effusion in Children Following Diagnosis of Acute Otitis Media, as Measured by Tympanograms and Acoustic Reflectometry
Status: Enrolling
Updated:  8/28/2017
University of New England College of Osteopathic Medicine
mi
from
Biddeford, ME
Osteopathic Otitis Media Research Study
Effect of Osteopathic Manipulative Medicine (OMM) on the Duration of Middle Ear Effusion in Children Following Diagnosis of Acute Otitis Media, as Measured by Tympanograms and Acoustic Reflectometry
Status: Enrolling
Updated: 8/28/2017
University of New England College of Osteopathic Medicine
mi
from
Biddeford, ME
Click here to add this to my saved trials
Osteopathic Otitis Media Research Study
Effect of Osteopathic Manipulative Medicine (OMM) on the Duration of Middle Ear Effusion in Children Following Diagnosis of Acute Otitis Media, as Measured by Tympanograms and Acoustic Reflectometry
Status: Enrolling
Updated:  8/28/2017
West Virginia School of Osteopathic Medicine
mi
from
Lewisburg, WV
Osteopathic Otitis Media Research Study
Effect of Osteopathic Manipulative Medicine (OMM) on the Duration of Middle Ear Effusion in Children Following Diagnosis of Acute Otitis Media, as Measured by Tympanograms and Acoustic Reflectometry
Status: Enrolling
Updated: 8/28/2017
West Virginia School of Osteopathic Medicine
mi
from
Lewisburg, WV
Click here to add this to my saved trials
Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method
A Single-Dose, Randomized, Double-Blind, Placebo-Controlled Onset-of-Action Study Utilizing the Double-Stopwatch Method
Status: Enrolling
Updated:  8/30/2017
University of Connecticut - Student Health Services
mi
from
Storrs, CT
Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method
A Single-Dose, Randomized, Double-Blind, Placebo-Controlled Onset-of-Action Study Utilizing the Double-Stopwatch Method
Status: Enrolling
Updated: 8/30/2017
University of Connecticut - Student Health Services
mi
from
Storrs, CT
Click here to add this to my saved trials
Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing
HIF-1 Regulated Circulating Angiogenic Cell Recruitment in Burn Wound Healing
Status: Enrolling
Updated:  8/31/2017
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing
HIF-1 Regulated Circulating Angiogenic Cell Recruitment in Burn Wound Healing
Status: Enrolling
Updated: 8/31/2017
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
Indiana University
mi
from
Indianapolis, IN
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
University of Iowa
mi
from
Iowa City, IA
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
University of Michigan
mi
from
Ann Arbor, MI
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated:  8/31/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Trial of High Dose Vitamin D in Patient's With Crohn's Disease
A Randomized Controlled Trial of High-Dose Vitamin D in Crohn's Disease
Status: Enrolling
Updated: 8/31/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
A Pivotal, Placebo Controlled, Phase III Study to Compare Efficacy and Tolerability of a Fixed Combination, Containing 500 mg ASA and 30 mg Pseudoephedrine, in Comparison to Its Single Components in Patients With Sore Throat and Nasal Congestion
Status: Enrolling
Updated:  8/31/2017
Clinical Research Facility
mi
from
New York, NY
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
A Pivotal, Placebo Controlled, Phase III Study to Compare Efficacy and Tolerability of a Fixed Combination, Containing 500 mg ASA and 30 mg Pseudoephedrine, in Comparison to Its Single Components in Patients With Sore Throat and Nasal Congestion
Status: Enrolling
Updated: 8/31/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
A Pivotal, Placebo Controlled, Phase III Study to Compare Efficacy and Tolerability of a Fixed Combination, Containing 500 mg ASA and 30 mg Pseudoephedrine, in Comparison to Its Single Components in Patients With Sore Throat and Nasal Congestion
Status: Enrolling
Updated:  8/31/2017
mi
from
Alassio,
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
A Pivotal, Placebo Controlled, Phase III Study to Compare Efficacy and Tolerability of a Fixed Combination, Containing 500 mg ASA and 30 mg Pseudoephedrine, in Comparison to Its Single Components in Patients With Sore Throat and Nasal Congestion
Status: Enrolling
Updated: 8/31/2017
mi
from
Alassio,
Click here to add this to my saved trials
Dysfunctional Hemoglobin Pulse Oximetry
Dysfunctional Hemoglobin Pulse Oximeter
Status: Enrolling
Updated:  8/31/2017
HPPL Duke Univeristy
mi
from
Durham, NC
Dysfunctional Hemoglobin Pulse Oximetry
Dysfunctional Hemoglobin Pulse Oximeter
Status: Enrolling
Updated: 8/31/2017
HPPL Duke Univeristy
mi
from
Durham, NC
Click here to add this to my saved trials
High-strength Glass-ionomer Dental Restorations
Clinical Performance of High-Viscous Glass-Ionomer Restorative Systems In Class II Lesions
Status: Enrolling
Updated:  9/5/2017
Mott Children's Health Center
mi
from
Flint, MI
High-strength Glass-ionomer Dental Restorations
Clinical Performance of High-Viscous Glass-Ionomer Restorative Systems In Class II Lesions
Status: Enrolling
Updated: 9/5/2017
Mott Children's Health Center
mi
from
Flint, MI
Click here to add this to my saved trials
Speech Perception for Children With Cochlear Implants
Speech Perception in Noise for Children With Cochlear Implants
Status: Enrolling
Updated:  9/7/2017
The Mayo Clinic
mi
from
Rochester, MN
Speech Perception for Children With Cochlear Implants
Speech Perception in Noise for Children With Cochlear Implants
Status: Enrolling
Updated: 9/7/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
A Randomized, Open-labeled, Pilot Study Comparing Weight Gain in Adults With AIDS-related Wasting Given Either Megestrol Acetate Oral Suspension Nanocrystal Dispersion (MA-NCD) or Megestrol Acetate Oral Suspension (Megace)
Status: Enrolling
Updated:  9/7/2017
Drexel University College of Medicine
mi
from
Philadelphia, PA
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
A Randomized, Open-labeled, Pilot Study Comparing Weight Gain in Adults With AIDS-related Wasting Given Either Megestrol Acetate Oral Suspension Nanocrystal Dispersion (MA-NCD) or Megestrol Acetate Oral Suspension (Megace)
Status: Enrolling
Updated: 9/7/2017
Drexel University College of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
A Randomized, Open-labeled, Pilot Study Comparing Weight Gain in Adults With AIDS-related Wasting Given Either Megestrol Acetate Oral Suspension Nanocrystal Dispersion (MA-NCD) or Megestrol Acetate Oral Suspension (Megace)
Status: Enrolling
Updated:  9/7/2017
Victoria Hospital
mi
from
Bangalore,
Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss
A Randomized, Open-labeled, Pilot Study Comparing Weight Gain in Adults With AIDS-related Wasting Given Either Megestrol Acetate Oral Suspension Nanocrystal Dispersion (MA-NCD) or Megestrol Acetate Oral Suspension (Megace)
Status: Enrolling
Updated: 9/7/2017
Victoria Hospital
mi
from
Bangalore,
Click here to add this to my saved trials
The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older
A Randomized, Wait-list Controlled Clinical Trial: the Effect of a Physical Activity Program on Fatigue After Potentially Curative Chemotherapy Among Cancer Survivors Age 65 or Older -- PACT (Physical Activity After Chemotherapy)
Status: Enrolling
Updated:  9/11/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older
A Randomized, Wait-list Controlled Clinical Trial: the Effect of a Physical Activity Program on Fatigue After Potentially Curative Chemotherapy Among Cancer Survivors Age 65 or Older -- PACT (Physical Activity After Chemotherapy)
Status: Enrolling
Updated: 9/11/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Cardiac Output Monitoring in Burn Patients
Non-invasive Cardiac Output Monitoring in Patients With Burn Injuries
Status: Enrolling
Updated:  9/11/2017
Grady Memorial Hospital
mi
from
Atlanta, GA
Cardiac Output Monitoring in Burn Patients
Non-invasive Cardiac Output Monitoring in Patients With Burn Injuries
Status: Enrolling
Updated: 9/11/2017
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers
Glutathione S Transferase M1 (GSTM1) Genotype Associated Susceptibility to Airway Response to Ozone in Mild Asthmatic Volunteers.
Status: Enrolling
Updated:  9/12/2017
Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers
Glutathione S Transferase M1 (GSTM1) Genotype Associated Susceptibility to Airway Response to Ozone in Mild Asthmatic Volunteers.
Status: Enrolling
Updated: 9/12/2017
Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus
Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus
Status: Enrolling
Updated:  9/13/2017
Nils Hasselmo Hall, 6-105
mi
from
Minneapolis, MN
Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus
Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus
Status: Enrolling
Updated: 9/13/2017
Nils Hasselmo Hall, 6-105
mi
from
Minneapolis, MN
Click here to add this to my saved trials